{"title":"[Management of Type 1 Gastric Neuroendocrine Tumors Less than 10 mm in Diameter].","authors":"Jae Kyu Sung","doi":"10.7704/kjhugr.2022.0065","DOIUrl":"10.7704/kjhugr.2022.0065","url":null,"abstract":"","PeriodicalId":22895,"journal":{"name":"The Korean Journal of Helicobacter and Upper Gastrointestinal Research","volume":" ","pages":"76-78"},"PeriodicalIF":0.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11967538/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42024595","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Homogenous Subepithelial Esophageal Lesion.","authors":"Jin Ook Jang, Su Jin Kim, Cheol Woong Choi","doi":"10.7704/kjhugr.2023.0004","DOIUrl":"10.7704/kjhugr.2023.0004","url":null,"abstract":"","PeriodicalId":22895,"journal":{"name":"The Korean Journal of Helicobacter and Upper Gastrointestinal Research","volume":" ","pages":"73-75"},"PeriodicalIF":0.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11967449/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46171149","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Probiotic Supplementation for Treatment of <i>Helicobacter pylori</i> Infection: A Double-Blind Randomized Clinical Trial.","authors":"Na Rae Lim, Soo Yeon Choi, Woo Chul Chung","doi":"10.7704/kjhugr.2022.0051","DOIUrl":"10.7704/kjhugr.2022.0051","url":null,"abstract":"<p><strong>Background/aims: </strong>The effects of probiotic supplementation on <i>Helicobacter pylori (H. pylori)</i> eradication therapy are not completely understood. In this study, we investigated the effects of continuous probiotic administration on eradication rates, recrudescence, and symptom response following completion of a course of <i>H. pylori</i> therapy.</p><p><strong>Methods: </strong>This prospective, randomized, double-blind placebo-controlled trial was performed between June 2018 and 2020. Twohundred seventy patients who received a standard triple regimen for <i>H. pylori</i> eradication, were included in the study. Participants were randomized to receive a probiotic as adjunctive therapy (<i>Enterococcus faecium</i> 4.5×10<sup>8</sup> and Bacillus subtilis 5.0×10<sup>7</sup>; Medilac-S<sup>®</sup>, Hanmi Pharmaceuticals, Seoul, Korea) or a placebo (one tablet thrice daily) for 28 days, following <i>H. pylori</i> eradication. Participants who showed successful eradication underwent a repeat <sup>13</sup>C-urea breath test after 6 months.</p><p><strong>Results: </strong>Eradication rates in the probiotic and placebo groups were 77.1% and 72.4%, respectively (<i>P</i>=0.48) using per-protocol analysis. Using intention-to-treat analysis, eradication rates were 67.4% and 65.9%, respectively (<i>P</i>=0.43). Of 149 patients who were followed-up after 6 months, four patients had recrudescence (2.7%). Recrudescence rates did not differ between the probiotic and placebo groups. Of the 76 patients who had non-ulcer dyspepsia, 60 (78.9%) showed symptom resolution after 6 months. This beneficial effect was most pronounced in patients with postprandial distress syndrome (<i>P</i>=0.02).</p><p><strong>Conclusions: </strong>Consecutive probiotic supplementation following <i>H. pylori</i> eradication therapy did not increase eradication rates or decrease recrudescence rates.</p>","PeriodicalId":22895,"journal":{"name":"The Korean Journal of Helicobacter and Upper Gastrointestinal Research","volume":" ","pages":"34-41"},"PeriodicalIF":0.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11967510/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44259628","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"[Approach to Small Gastric Subepithelial Lesions].","authors":"Moon Won Lee, Bong Eun Lee","doi":"10.7704/kjhugr.2023.0020","DOIUrl":"10.7704/kjhugr.2023.0020","url":null,"abstract":"<p><p>Gastric subepithelial lesions (SELs) are often detected incidentally during upper gastrointestinal endoscopy. Although most SELs are benign, endoscopic differentiation between malignant and benign lesions is important. Endoscopy is useful to determine the location, color, consistency, mobility, surface characteristics, and approximate size of gastric SELs. EUS can distinguish between intraluminal lesions and extraluminal compression and confirm the exact size, layer of origin, echogenicity, and homogeneity of SELs. Accurate understanding of the endoscopic and EUS features of gastric SELs is useful to effectively design an appropriate management plan and thereby minimize the rate of unnecessary surveillance or overtreatment.</p>","PeriodicalId":22895,"journal":{"name":"The Korean Journal of Helicobacter and Upper Gastrointestinal Research","volume":" ","pages":"28-33"},"PeriodicalIF":0.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11967486/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44038178","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"[Approach to Patients after Successful Eradication of <i>Helicobacter pylori</i>].","authors":"Hee Seok Moon","doi":"10.7704/kjhugr.2023.0019","DOIUrl":"10.7704/kjhugr.2023.0019","url":null,"abstract":"<p><p><i>Helicobacter pylori</i> (<i>H. pylori</i>) is a well-known gastrointestinal microorganism that causes chronic gastritis and peptic ulcers, which may evolve into gastric cancer. Previous studies have shown that <i>H. pylori</i> eradication inhibits the development of primary and metachronous gastric cancer. Therefore, the Kyoto global consensus recommends eradication therapy for both symptomatic and asymptomatic <i>H. pylori</i>-infected patients. Gastric cancer is detected even in patients after successful <i>H. pylori</i> eradication. Recent studies have reported the role of endoscopy in detection of primary gastric cancers after <i>H. pylori</i> eradication. Development of gastric cancer may be observed several months or even >10 years after successful <i>H. pylori</i> eradication. Therefore, identification of high-risk patients in whom extensive surveillance may prove beneficial represents a clinical dilemma. In this review, the characteristics of gastric cancer patients who have undergone successful <i>H. pylori</i>-eradication therapy are summarized.</p>","PeriodicalId":22895,"journal":{"name":"The Korean Journal of Helicobacter and Upper Gastrointestinal Research","volume":" ","pages":"22-27"},"PeriodicalIF":0.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11967540/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43692428","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"[Approach to Patients with Consecutive <i>Helicobacter pylori</i> Eradication Failure].","authors":"Sung Eun Kim","doi":"10.7704/kjhugr.2023.0017","DOIUrl":"10.7704/kjhugr.2023.0017","url":null,"abstract":"<p><p><i>Helicobacter pylori</i> (<i>H. pylori</i>) is associated with various gastrointestinal disorders, such as gastritis, peptic ulcers, mucosa-associated lymphoid tissue lymphoma, and gastric cancer. Therefore, the International Agency for Research on Cancer, a specialized cancer agency of the World Health Organization, categorizes <i>H. pylori</i> as a definite gastric carcinogen (group I). <i>H. pylori</i> eradication is a major challenge both medically and socioeconomically in countries with high prevalence of <i>H. pylori</i> and gastric cancer. However, the efficacy of first-line clarithromycin-containing triple therapy and second-line bismuth-containing quadruple therapy continues to decline worldwide including in Korea. The role of salvage therapy is being recognized globally; however, the exact salvage therapy which is useful in daily clinical practice remains unestablished. In this review, factors associated with eradication failure will be discussed. Furthermore, eradication regimens that may be useful as salvage therapies based on Korean guidelines, Maastricht VI/Florence consensus report and previous research are summarized.</p>","PeriodicalId":22895,"journal":{"name":"The Korean Journal of Helicobacter and Upper Gastrointestinal Research","volume":" ","pages":"15-21"},"PeriodicalIF":0.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11967542/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42226691","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Eui Sun Jeong, Hye-Kyung Jung, Ju Ran Byeon, Ayoung Lee, Ji Taek Hong, Seong-Eun Kim, Chang Mo Moon
{"title":"Prediction of Severity and Adverse Outcomes Associated with Perforation in Patients Presenting to the Emergency Department with Esophageal Injury.","authors":"Eui Sun Jeong, Hye-Kyung Jung, Ju Ran Byeon, Ayoung Lee, Ji Taek Hong, Seong-Eun Kim, Chang Mo Moon","doi":"10.7704/kjhugr.2022.0057","DOIUrl":"10.7704/kjhugr.2022.0057","url":null,"abstract":"<p><strong>Background/aims: </strong>Esophageal perforation is associated with high mortality and morbidity in patients presenting to the emergency department (ED) with esophageal injury. We investigated the effectiveness of initial CT scan in patients with esophageal injury to determine the risk factors for complications.</p><p><strong>Methods: </strong>Patients admitted through the ED for evaluation of esophageal injuries between January 2001 and May 2020, were investigated. Demographic data, etiological factors, comorbidities, treatment administered, and outcomes were collected. Esophageal injury was graded based on the following CT criteria: (a) normal, (b) pneumomediastinum, (c) mediastinitis, fluid collection, abscess, or overt esophageal wall injury, and (d) pleural effusion, subcutaneous emphysema, or pneumothorax. Grade 2 was defined as microperforation and grades 3 and 4 as overt perforation.</p><p><strong>Results: </strong>Of 281 patients with esophageal injury, 38 had CT-documented overt perforations and 20 had microperforations. Foreign body-induced injury (n=37), Boerhaave syndrome (n=12), and chemical injury (n=3) were common causes of esophageal injury. Complications occurred in 24 (8.5%) patients. Risk factors for complications were age ≥65 years (OR 4.14, 95% CI 1.18~14.56, <i>P</i>=0.027), cerebrovascular disease (OR 8.58, 95% CI 1.13~65.19, <i>P</i>=0.038), Boerhaave syndrome (OR 12.52, 95% CI 2.07~75.68, <i>P</i>=0.006), chemical injury (OR 15.72, 95% CI 3.67~67.28, <i>P</i><0.001), and CT-documented grade 4 perforation (OR 15.75, 95% CI 4.39~56.55, <i>P</i><0.001).</p><p><strong>Conclusions: </strong>Initial CT-based grading in the ED are useful for predicting potential complications and for managing patients with esophageal injury and suspected perforation.</p>","PeriodicalId":22895,"journal":{"name":"The Korean Journal of Helicobacter and Upper Gastrointestinal Research","volume":" ","pages":"42-51"},"PeriodicalIF":0.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11967457/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46193226","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"[Is Probiotic Supplementation Useful for <i>Helicobacter pylori</i> Eradication?]","authors":"Ki-Nam Shim","doi":"10.7704/kjhugr.2023.0007","DOIUrl":"10.7704/kjhugr.2023.0007","url":null,"abstract":"","PeriodicalId":22895,"journal":{"name":"The Korean Journal of Helicobacter and Upper Gastrointestinal Research","volume":" ","pages":"1-3"},"PeriodicalIF":0.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11967497/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43286378","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"[Gastric Inverted Hyperplastic Polyp Removed Using Endoscopic Submucosal Dissection].","authors":"Jee Won Boo, Joon Sung Kim, Byung-Wook Kim","doi":"10.7704/kjhugr.2022.0059","DOIUrl":"10.7704/kjhugr.2022.0059","url":null,"abstract":"<p><p>Gastric subepithelial tumors (SETs) are usually asymptomatic and are often detected incidentally during screening endoscopy. A gastric inverted hyperplastic polyp (IHP) is characterized by downward growth of hyperplastic mucosa into the submucosal layer. Owing to these characteristics, a gastric IHP is frequently misdiagnosed as a SET. Gastric IHPs are asymptomatic in most cases and are discovered incidentally. Notably, IHPs may be accompanied by an adenocarcinoma or anemia owing to chronic bleeding associated with this lesion; therefore, endoscopic submucosal dissection is recommended for complete excision of IHPs measuring > 2 cm. We report a case of gastric IHP that was diagnosed during screening endoscopy in an asymptomatic patient. We observed a whitish purulent exudate expressed from the SET, and endoscopic ultrasonography revealed a SET originating from the muscularis mucosa. Endoscopic submucosal dissection was performed to remove the SET, and final histopathological findings revealed a gastric IHP. This case report highlights that IHPs should be suspected in patients with a SET associated with whitish exudates.</p>","PeriodicalId":22895,"journal":{"name":"The Korean Journal of Helicobacter and Upper Gastrointestinal Research","volume":" ","pages":"63-67"},"PeriodicalIF":0.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11967531/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43753419","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"[Clinical Efficacy of Transcatheter Arterial Embolization for Acute Non-Variceal Gastrointestinal Bleeding].","authors":"Won Shik Kim, Moon Kyung Joo","doi":"10.7704/kjhugr.2023.0002","DOIUrl":"10.7704/kjhugr.2023.0002","url":null,"abstract":"","PeriodicalId":22895,"journal":{"name":"The Korean Journal of Helicobacter and Upper Gastrointestinal Research","volume":" ","pages":"4-6"},"PeriodicalIF":0.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11967549/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44472472","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}